Ross J. Baldessarini
#61,184
Most Influential Person Now
Researcher
Ross J. Baldessarini's AcademicInfluence.com Rankings
Ross J. Baldessarinimedical Degrees
Medical
#458
World Rank
#628
Historical Rank
#185
USA Rank
Pharmacology
#31
World Rank
#40
Historical Rank
#13
USA Rank
Ross J. Baldessariniphilosophy Degrees
Philosophy
#2081
World Rank
#3634
Historical Rank
#779
USA Rank
Logic
#429
World Rank
#817
Historical Rank
#171
USA Rank
Download Badge
Medical Philosophy
Ross J. Baldessarini's Degrees
- Doctorate Medicine University of Milan
- PhD Pharmacology University of Milan
Why Is Ross J. Baldessarini Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ross J. Baldessarini , a psychopharmacologist, is the Director, International Consortium for Bipolar & Psychotic Disorders Research at McLean Hospital and Professor of Psychiatry at Harvard Medical School.
Ross J. Baldessarini's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International consensus study of antipsychotic dosing. (2010) (1090)
- Drugs and the treatment of psychiatric disorders (1996) (918)
- One hundred years of schizophrenia: a meta-analysis of the outcome literature. (1994) (603)
- The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
- Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. (1988) (503)
- Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. (2006) (503)
- Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. (2000) (496)
- Clozapine. A novel antipsychotic agent. (1991) (494)
- The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. (1985) (490)
- Practice guideline for the assessment and treatment of patients with suicidal behaviors. (2003) (488)
- False neurotransmitters and hepatic failure. (1971) (454)
- Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. (2007) (449)
- Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. (1974) (446)
- The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. (2003) (442)
- The predictive power of diagnostic tests and the effect of prevalence of illness. (1983) (432)
- One hundred years of schizophrenia: A meta-analysis of the outcome literature (1993) (398)
- Modern antipsychotic drugs: a critical overview (2005) (372)
- Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. (1991) (371)
- Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. (2000) (310)
- Comparative postnatal development of dopamine D1, D2 and D4 receptors in rat forebrain (2000) (308)
- Suicidal Behaviour in Bipolar Disorder (2003) (293)
- Effects of Newer Antipsychotics on Extrapyramidal Function (2002) (288)
- Changes in prevalence, severity, and recovery in tardive dyskinesia with age. (1980) (279)
- Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. (2007) (272)
- A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. (1989) (266)
- Motor effects of serotonin in the central nervous system. (1980) (266)
- Neurocognitive impairment in bipolar disorder patients: functional implications. (2009) (260)
- Disability and its treatment in bipolar disorder patients. (2007) (258)
- Antidepressant treatment in bipolar versus unipolar depression. (2004) (248)
- The dexamethasone suppression test: An overview of its current status in psychiatry (1987) (247)
- Suicidal risk during treatment with clozapine: a meta-analysis (2005) (245)
- Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. (1997) (242)
- Lower suicide risk with long‐term lithium treatment in major affective illness: a meta‐analysis (2001) (240)
- Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials (2011) (233)
- Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. (2004) (231)
- Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. (1999) (231)
- Genetics of Suicide: An Overview (2004) (223)
- Tissue Concentrations of Clozapine and its Metabolites in the Rat (1993) (219)
- Mania associated with antidepressant treatment: comprehensive meta‐analytic review (2009) (216)
- Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. (1993) (216)
- Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. (1973) (215)
- Episodes of mood disorders in 2,252 pregnancies and postpartum periods. (2011) (212)
- Lithium treatment and suicide risk in major affective disorders: update and new findings. (2003) (205)
- Neuroleptic withdrawal in schizophrenic patients. (1995) (203)
- Suicide attempts in major affective disorder patients with comorbid substance use disorders. (1999) (200)
- A sensitive and specific enzymatic isotopic assay for tissue histamine. (1966) (198)
- Effects of lithium on cognitive performance: a meta-analysis. (2009) (198)
- Pediatric bipolar disorder: phenomenology and course of illness. (2004) (197)
- Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review (2012) (196)
- Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. (2013) (195)
- Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: Review of the evidence (2013) (195)
- Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics? (2006) (193)
- Factors associated with treatment nonadherence among US bipolar disorder patients (2008) (193)
- EEG abnormalities during treatment with typical and atypical antipsychotics. (2002) (187)
- Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi (1998) (186)
- Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. (1980) (185)
- Metabolism of norepinephrine in the central nervous system. (1966) (184)
- Pathophysiologic basis of tardive dyskinesia. (1977) (182)
- Animal models of attention-deficit hyperactivity disorder (2003) (181)
- Lithium treatment reduces suicide risk in recurrent major depressive disorder. (2007) (177)
- Lithium treatment and risk of suicidal behavior in bipolar disorder patients. (1998) (172)
- Suicide in Bipolar Disorder: Risks and Management (2006) (170)
- Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. (2008) (169)
- Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. (2006) (167)
- Postnatal Development of Dopamine D1-Like Receptors in Rat Cortical and Striatolimbic Brain Regions: An Autoradiographic Study (1999) (167)
- Suicide rates in relation to health care access in the United States: an ecological study. (2006) (165)
- Does lithium treatment still work? Evidence of stable responses over three decades. (2000) (165)
- Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. (1997) (164)
- Mood, vegetative disturbance, and dexamethasone suppression test after stroke (1982) (163)
- The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis (2000) (162)
- Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. (1994) (162)
- Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. (1998) (161)
- Current status of antidepressants: clinical pharmacology and therapy. (1989) (160)
- Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. (2008) (159)
- Pediatric‐Onset Bipolar Disorder: A Neglected Clinical and Public Health Problem Gianni (1995) (156)
- Chemotherapy in psychiatry : principles and practice (1985) (154)
- Lithium in breast milk and nursing infants: clinical implications. (2007) (153)
- A plea for integrity of the bipolar disorder concept. (2000) (153)
- Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. (1996) (152)
- Efficacy of antidepressants in juvenile depression: meta-analysis (2008) (151)
- Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. (1989) (151)
- Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. (2005) (151)
- Effect of Lithium Maintenance on. Suicidal Behavior in Major Mood Disorders a (1997) (149)
- Cognition and disability in bipolar disorder: lessons from schizophrenia research. (2010) (147)
- The basis for amine hypotheses in affective disorders. A critical evaluation. (1975) (146)
- McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. (2009) (146)
- Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. (1975) (145)
- Bipolar Depression: Overview and Commentary (2010) (145)
- Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. (1993) (144)
- Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. (1996) (143)
- Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. (2007) (142)
- N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. (1994) (142)
- Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2015) (140)
- S‐ADENOSYLMETHIONINE IN BRAIN AND OTHER TISSUES (1966) (139)
- Fluoxetine and side effects. (1990) (138)
- Discontinuing Antidepressant Treatment in Major Depression (1998) (138)
- Do Central Antiadrenergic Actions Contribute to the Atypical Properties of Clozapine? (1992) (137)
- Treatment of schizophrenia 1999 (1999) (136)
- Age at onset versus family history and clinical outcomes in 1,665 international bipolar‐I disorder patients (2012) (135)
- Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. (2001) (134)
- Pharmacologically induced behavioural supersensitivity to apomorphine. (1973) (134)
- Neuropharmacology of S-adenosyl-L-methionine. (1987) (133)
- Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. (1994) (132)
- Circadian locomotor activity rhythms in Alzheimer's disease. (1991) (132)
- ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth (2006) (132)
- Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. (1998) (131)
- Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. (2013) (128)
- The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. (1967) (127)
- Suicide risk and treatments for patients with bipolar disorder. (2003) (127)
- Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. (2007) (126)
- Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. (1999) (125)
- Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. (2007) (125)
- Predominant recurrence polarity among 928 adult international bipolar I disorder patients (2012) (123)
- Rapid cycling in women and men with bipolar manic-depressive disorders. (1998) (122)
- Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine (1975) (120)
- Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2- and D4-like receptors (1998) (120)
- Reduced suicide risk during lithium maintenance treatment. (2000) (119)
- Clozapine in severe mood disorders. (1995) (119)
- A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings. (1989) (119)
- Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. (1995) (118)
- Dissimilar dosing with high-potency and low-potency neuroleptics. (1984) (116)
- Morbidity in 303 first-episode bipolar I disorder patients. (2010) (116)
- Pharmacological treatment of adult bipolar disorder (2019) (116)
- Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. (2001) (114)
- Differential associations of affective temperaments and diagnosis of major affective disorders with suicidal behavior. (2017) (114)
- Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. (2015) (113)
- Substance abuse in first-episode bipolar I disorder: indications for early intervention. (2005) (111)
- L-Dihydroxyphenylalanine: Effect on S-Adenosylmethionine in Brain (1970) (110)
- Calcium leakage as a cause of the high resting tension in vascular smooth muscle from the spontaneously hypertensive rat. (1978) (110)
- Inpatient antipsychotic drug use in 1998, 1993, and 1989. (2002) (109)
- Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. (2000) (107)
- Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. (2010) (105)
- Rapid‐cycling bipolar disorder: effects of long‐term treatments (2003) (103)
- Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. (1991) (103)
- Managing Bipolar Disorder during Pregnancy: Weighing the Risks and Benefits (2002) (102)
- Effectiveness of Psychosocial Treatments in Bipolar Disorder: State of the Evidence (2000) (101)
- Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions (2002) (101)
- Clinical use of lithium salts: guide for users and prescribers (2019) (100)
- Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms (2006) (100)
- Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical (1996) (100)
- Manic‐Depressive Illness: Evolution in Kraepelin's Textbook, 1883–1926 (2005) (100)
- Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. (2004) (99)
- McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. (2011) (97)
- Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders (2001) (97)
- Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. (2003) (96)
- Developmental Differences in Acute Nigrostriatal and Mesocorticolimbic System Response to Haloperidol (1993) (95)
- Treatments for Acute Bipolar Depression: Meta-analyses of Placebo-controlled, Monotherapy Trials of Anticonvulsants, Lithium and Antipsychotics (2014) (95)
- Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. (1984) (94)
- Effects of L-dopa on norepinephrine metabolism in the brain. (1971) (93)
- Onset-age of bipolar disorders at six international sites. (2010) (93)
- Localization of ionotropic glutamate receptors in caudate‐putamen and nucleus accumbens septi of rat brain: Comparison of NMDA, AMPA, and kainate receptors (1998) (92)
- Bipolar depression: a major unsolved challenge (2020) (92)
- Advances in development of dopaminergic aporphinoids. (2007) (92)
- Factors associated with noncompliance with psychiatric outpatient visits. (2001) (90)
- Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. (2008) (90)
- Weight loss in overweight patients maintained on atypical antipsychotic agents (2006) (89)
- Illness risk following rapid versus gradual discontinuation of antidepressants. (2010) (89)
- Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women After Discontinuing Lithium Maintenance (2000) (88)
- A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania (2014) (88)
- Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. (2002) (88)
- Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. (2002) (86)
- Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. (1993) (86)
- Suicidal risk in antidepressant drug trials. (2006) (85)
- Overview of antidepressant treatment of bipolar depression. (2013) (85)
- Risperidone in the elderly: a pharmacoepidemiologic study. (1997) (85)
- Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. (1996) (84)
- Clinical risk factors for bipolar disorders: a systematic review of prospective studies. (2014) (84)
- Long-Term Effects of Olanzapine, Risperidone, and Quetiapine on Ionotropic Glutamate Receptor Types: Implications for Antipsychotic Drug Treatment (2003) (83)
- Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats (2001) (83)
- Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine (1991) (82)
- 5-hydroxytryptophan-induced myoclonus: Increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat (1976) (82)
- Prophylaxis Latency and Outcome in Bipolar Disorders (2003) (82)
- What is the best maintenance dose of neuroleptics in schizophrenia? (1980) (82)
- Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. (2001) (82)
- Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. (2003) (81)
- Treating the Suicidal Patient with Bipolar Disorder (2001) (81)
- Adverse Endocrine and Metabolic Effects of Psychotropic Drugs (2009) (81)
- N-Substituted Analogs of 2β-Carbomethoxy-3β-(4‘-iodophenyl)tropane (β-CIT) with Selective Affinity to Dopamine or Serotonin Transporters in Rat Forebrain (1996) (80)
- Regulation of Working Memory by Dopamine D4 Receptor in Rats (2004) (80)
- Is lithium still worth using? An update of selected recent research. (2002) (80)
- Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. (1979) (80)
- Lamotrigine in bipolar disorder: efficacy during pregnancy. (2008) (80)
- Frequency of diagnoses of schizophrenia versus affective disorders from 1944 to 1968. (1970) (79)
- Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning (2002) (79)
- Parvalbumin Neurons in the Entorhinal Cortex of Subjects Diagnosed With Bipolar Disorder or Schizophrenia (2007) (78)
- CO‐OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW (2014) (77)
- Differential effects of serotonin on turning and stereotypy induced by apomorphine (1975) (77)
- Regional distribution of dopamine D4 receptors in rat forebrain (1997) (77)
- Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. (1993) (77)
- Suicidal risk factors in bipolar I and II disorder patients. (2012) (77)
- Alterations in tissue levels of S-adenosylmethionine. (1966) (76)
- Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. (2004) (76)
- Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods (2009) (76)
- Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review (2013) (75)
- Ecological Studies of Antidepressant Treatment and Suicidal Risks (2007) (75)
- Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. (2011) (75)
- Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups (2003) (74)
- Clozapine Pharmacokinetics in Children and Adolescents with Childhood-Onset Schizophrenia (2003) (73)
- Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects. (1978) (73)
- Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters (2017) (73)
- Episode sequence in bipolar disorder and response to lithium treatment. (1991) (72)
- Systematic Review of Clozapine Cardiotoxicity (2016) (72)
- What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium (2019) (71)
- Dopamine D4 receptors: significance for molecular psychiatry at the millennium (1999) (70)
- Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. (2008) (70)
- Precursors of bipolar disorders: a systematic literature review of prospective studies. (2015) (69)
- Depression and Mania in Bipolar Disorder (2017) (69)
- Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients (2009) (69)
- Effects of medical interventions on suicidal behavior. Summary and conclusions. (1999) (68)
- Advances in Atypical Antipsychotics for the Treatment of Schizophrenia (2002) (68)
- Weygandt's On the Mixed States of Manic-Depressive Insanity: A Translation and Commentary on Its Significance in the Evolution of the Concept of Bipolar Disorder (2002) (68)
- Drugs Five Years Later: Lithium Salts: 1970-1975 (1975) (68)
- Maintenance treatment in bipolar disorder. (2000) (67)
- Compounds selective for dopamine receptor subtypes (1997) (67)
- THE UPTAKE AND SUBCELLULAR DISTRIBUTION OF AROMATIC AMINES IN THE BRAIN OF THE RAT 1 (1971) (67)
- Sex differences in response to lithium treatment. (2000) (66)
- Lithium carbonate for affective disorders. I. Clinical pharmacology and toxicology. (1970) (66)
- Tyrosine for depression: a double-blind trial. (1990) (65)
- Chemotherapy in psychiatry (2013) (65)
- Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. (2009) (65)
- Extra length of stay and costs because of health care-associated infections at a German university hospital. (2016) (65)
- Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations. (1988) (65)
- Discontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications (1993) (65)
- Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment (2016) (64)
- Factors associated with functional recovery in bipolar disorder patients. (2010) (64)
- Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials (2015) (63)
- Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. (1988) (63)
- Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat (1978) (63)
- S-adenosylmethionine and catechol-O-methyl-transferase in schizophrenia. (1972) (63)
- Bipolar disorders following initial depression: modeling predictive clinical factors. (2014) (63)
- METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS. (1965) (62)
- Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. (2012) (62)
- Lithium salts: 1970-1975. (1975) (62)
- Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. (1995) (62)
- (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue (1991) (61)
- Suicidal risk factors in major affective disorders (2019) (61)
- Evidence‐based options for treatment‐resistant adult bipolar disorder patients (2012) (61)
- Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. (1972) (60)
- Factors modifying drug and placebo responses in randomized trials for bipolar mania. (2011) (60)
- Duloxetine: Meta-analyses of Suicidal Behaviors and Ideation in Clinical Trials for Major Depressive Disorder (2006) (60)
- A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. (1993) (59)
- Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. (1990) (59)
- Time course of antipsychotic effects of neuroleptic drugs. (1989) (59)
- Long-Term Effects of S(+)N-n-Propylnorapomorphine Compared with Typical and Atypical Antipsychotics: Differential Increases of Cerebrocortical D2-Like and Striatolimbic D4-Like Dopamine Receptors (1997) (59)
- Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study. (1997) (58)
- The pharmacologic treatment of schizophrenia: a progress report. (1983) (58)
- Regional distribution of histamine in human brain. (1973) (58)
- Tritiated Norepinephrine: Release from Brain Slices by Electrical Stimulation (1966) (58)
- Dopamine D4 Receptors: Beyond Schizophrenia (2004) (58)
- Dopamine D1 receptor development depends on endogenous dopamine. (1990) (57)
- Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview (2009) (57)
- Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. (1997) (57)
- The uptake of (3H)dopamine by homogenates of rat corpus striatum: effects of cations. (1973) (56)
- Formation of catechol compounds from phenylalanine and tyrosine with isolated nerve endings. (1972) (56)
- Drug interactions with antipsychotic agents. (1993) (55)
- Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. (2010) (55)
- Gamma-aminobutyric acid esters. 1. Synthesis, brain uptake, and pharmacological studies of aliphatic and steroid esters of gamma-aminobutyric acid. (1984) (55)
- Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions (2002) (55)
- Tardive and withdrawal dyskinesia associated with haloperidol. (1974) (55)
- ASSAY OF TISSUE LEVELS OF S-ADENOSYLMETHIONINE. (1963) (54)
- Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. (2010) (54)
- Factors associated with length of psychiatric hospitalization. (2014) (54)
- Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. (1997) (54)
- Effects of Lithium and of pH on Synaptosomal Metabolism of Noradrenaline (1970) (54)
- Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions (1999) (53)
- Biochemical effects of dihydroxylated tryptamines on central indoleamine neurones. (1974) (53)
- Evidence for two types of binding of 3H-gaba and 3H-muscimol in rat cerebral cortex and cerebellum. (1979) (53)
- Reducing the risk for suicide in schizophrenia and affective disorders. (2003) (53)
- Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. (1984) (52)
- Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias. (2013) (52)
- A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. (1993) (52)
- Longitudinal research on bipolar disorders (2007) (52)
- Release of Catecholamines (1975) (52)
- Effects of risperidone on dopamine receptor subtypes in developing rat brain (2007) (52)
- Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder (2013) (51)
- Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial. (2005) (51)
- Pharmacological Approaches for Treatment-resistant Bipolar Disorder (2015) (51)
- Comparison of Electronic Screening for Suicidal Risk With the Patient Health Questionnaire Item 9 and the Columbia Suicide Severity Rating Scale in an Outpatient Psychiatric Clinic. (2015) (51)
- Relationships of local lithium concentrations in drinking water to regional suicide rates in Italy (2015) (51)
- Recovery and functional outcomes following olanzapine treatment for bipolar I mania. (2005) (51)
- Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions (1992) (50)
- Myoclonus after 5‐hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system (1976) (50)
- On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary. (2004) (50)
- Weight gain during treatment of bipolar I patients with olanzapine. (2004) (49)
- Suicidal Risk Following Hospital Discharge: A Review. (2019) (49)
- Tolerance to therapeutic effects of antidepressants. (1985) (49)
- An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder (2019) (48)
- Activation by cyclic 3':5'-adenosine monophosphate of tyrosine hydroxylase in the rat brain. (1975) (48)
- Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. (2006) (48)
- Antidepressant drug treatment for poststroke depression: retrospective study. (1987) (48)
- Enhanced expression of dopamine D1 and glutamate NMDA receptors in dopamine D4 receptor knockout mice (2007) (47)
- Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. (1989) (47)
- Scaling Behavior of Human Locomotor Activity Amplitude: Association with Bipolar Disorder (2011) (47)
- Tolerance in Antidepressant Treatment (2002) (47)
- Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. (1999) (47)
- Plasticity of Dopamine D4 Receptors in Rat Forebrain: Temporal Association with Motor Hyperactivity Following Neonatal 6-Hydroxydopamine Lesioning (2002) (46)
- Morbidity in Depressive Disorders (2017) (46)
- Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. (1994) (46)
- Radioreceptor assay of haloperidol tissue levels in the rat (1980) (46)
- Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics (2012) (46)
- Effects of electroconvulsive seizures on amine metabolism in the rat brain. (1973) (45)
- Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium? (2018) (45)
- Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. (2001) (44)
- Systematic Review of Blinding Assessment in Randomized Controlled Trials in Schizophrenia and Affective Disorders 2000-2010 (2013) (44)
- Antipsychotic drug use: McLean Hospital, 2002 (2005) (44)
- Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. (2012) (44)
- Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain (1988) (44)
- Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum (1975) (44)
- Clozapine toxicity associated with smoking cessation: case report. (2005) (43)
- Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview (2016) (42)
- Lithium and suicidal risk. (2008) (42)
- GABAB receptors: altered coupling to G-proteins in rats sensitized to amphetamine (2000) (42)
- Hospital use of antipsychotic drugs: polytherapy. (2008) (42)
- Trace amines and alternative neurotransmitters in the central nervous system. (1978) (42)
- UPTAKE AND RELEASE OF POSSIBLE FALSE TRANSMITTER AMINO ACIDS BY RAT BRAIN TISSUE 1 (1974) (42)
- Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. (1993) (42)
- Efficacy and tolerability of treatments for bipolar depression. (2015) (41)
- Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression (2015) (41)
- Does the dexamethasone suppression test have clinical utility in psychiatry? (1985) (41)
- Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials (2016) (41)
- Persistence of haloperidol in the brain. (1988) (41)
- Mixed symptoms in major depressive and bipolar disorders: A systematic review. (2018) (41)
- Tolerance to behavioral effects of haloperidol. (1981) (41)
- Isomeric selectivity at dopamine D3 receptors. (1993) (41)
- Increasing frequency of the diagnosis of obsessive-compulsive disorder. (1992) (41)
- Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat (1983) (41)
- Prolonged apomorphine-like behavioural effects of apomorphine esters (1976) (40)
- Use of combinations of antipsychotics: McLean Hospital inpatients, 2002 (2005) (40)
- Suicidal Risk and Affective Temperaments, Evaluated with the TEMPS-A Scale: A Systematic Review (2018) (40)
- Treatment delays in bipolar disorders. (1999) (40)
- Bipolar depression: clinical correlates of receiving antidepressants. (2012) (40)
- Thyroid Hormones in Depressive Disorders: A Reappraisal of Clinical Utility (1997) (39)
- Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. (1991) (39)
- Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. (2009) (39)
- Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic. (1984) (39)
- Options for Pharmacological Treatment of Refractory Bipolar Depression (2014) (39)
- Lithium treatment for unipolar major depressive disorder: Systematic review (2019) (38)
- Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004 (2010) (38)
- The pathophysiologic basis of tardive dyskinesia. (1977) (38)
- Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. (1993) (38)
- Repeated antipsychotic drug exposurein developing rats: Dopamine receptor effects (2006) (38)
- gamma-Aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of gamma-aminobutyric acid. (1985) (37)
- Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. (2009) (37)
- Coping styles: Longitudinal development from ages 17 to 33 and associations with psychiatric disorders (2015) (37)
- Brain dopamine D(4) receptors: basic and clinical status. (1999) (37)
- Risk of mania with antidepressants. (2005) (37)
- Dr. Stoll and Colleagues Reply (1993) (37)
- [3H]β-CIT: a radioligand for dopamine transporters in rat brain tissue (1999) (37)
- Effects of Treatment Discontinuation in Clinical Psychopharmacology (2019) (37)
- Treatment Research in Bipolar Disorder (2002) (36)
- Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. (2005) (36)
- Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat. (1980) (36)
- Neurosyphilis, Malaria, and the Discovery of Antipsychotic Agents (2008) (36)
- Affective temperaments and suicidal ideation and behavior in mood and anxiety disorder patients. (2016) (36)
- RBI-257: a highly potent dopamine D4 receptor-selective ligand. (1997) (36)
- Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. (2013) (36)
- Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. (2002) (35)
- S-(+)-aporphines are not selective for human D3 dopamine receptors (1994) (35)
- Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue. (1992) (35)
- Conversions from clozapine to other antipsychotic drugs. (1995) (35)
- Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain (1997) (35)
- Epidemiology of suicide: recent developments (2019) (35)
- Clinically Significant Interactions of Psychotropic Agents with Antipsychotic Drugs (1996) (35)
- Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist. (1990) (35)
- Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. (2005) (35)
- Oxcarbazepine: clinical experience with hospitalized psychiatric patients. (2003) (34)
- Characteristics of depressive and bipolar disorder patients with mixed features (2018) (34)
- New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. (1993) (34)
- Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain. (2002) (34)
- Correlates of recovery of social functioning in types I and II bipolar disorder patients (2010) (34)
- Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine. (1978) (34)
- Increased muscarinic receptor binding in rat forebrain after scopolamine. (1980) (34)
- Recurrence Risk in Bipolar Manic- Depressive Disorders after Discontinuing Lithium Maintenance Treatment: An Overview (1998) (33)
- Risks and implications of interrupting maintenance psychotropic drug therapy. (1995) (33)
- Leukopenia associated with addition of paroxetine to clozapine. (1998) (33)
- Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. (1992) (33)
- Biological transmethylation involving S-adenosylmethionine: development of assay methods and implications for neuropsychiatry. (1975) (33)
- The pathophysiological basis of tardive dyskinesia (1979) (33)
- REGIONAL RELEASE OF AROMATIC AMINES FROM TISSUES OF THE RAT BRAIN IN YITRO 1 (1972) (32)
- Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001-2008). (2011) (32)
- Primary and Drug‐Induced Disorders of Water Homeostasis in Psychiatric Patients: Principles of Diagnosis and Management (1998) (32)
- Mechanisms underlying tardive dyskinesia. (1976) (32)
- Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the Rat (1995) (32)
- Multi-Scale Motility Amplitude Associated with Suicidal Thoughts in Major Depression (2012) (32)
- Pretreatment episode count and response to lithium treatment in manic-depressive illness. (2003) (31)
- Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients (2014) (31)
- Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics (2019) (31)
- EFFECTS OF Mn2+ AND OTHER DIVALENT CATIONS ON ADENYLATE CYCLASE ACTIVITY IN RAT BRAIN 1 (1976) (31)
- Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. (1995) (31)
- Oral bioavailability of apomorphine in the rat with a portacaval venous anastomosis. (1980) (31)
- The Manic-Depressive Spectrum and Mood Stabilization: Kraepelin’s Ghost (2007) (31)
- Biochemical physiology of central synapses. (1973) (31)
- Aripiprazole: Initial Clinical Experience with 142 Hospitalized Psychiatric Patients (2005) (30)
- Features preceding diagnosis of bipolar versus major depressive disorders. (2015) (30)
- RELEASE OF AROMATIC AMINES FROM BRAIN TISSUES OF THE RAT IN VITRO 1 (1971) (30)
- Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. (2007) (30)
- Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008. (2011) (30)
- Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole (2005) (30)
- Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine. (1988) (30)
- Biological rhythms and mood disorders (2012) (30)
- Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK‐N‐BE(2)M17 cells and rat brain tissue (2002) (30)
- Suicidal Risks in 12 DSM-5 Psychiatric Disorders. (2020) (30)
- The Bipolar Book History, Neurobiology, and Treatment (2015) (29)
- Suicide Attempts in Juvenile Bipolar Versus Major Depressive Disorders: Systematic Review and Meta-Analysis. (2017) (29)
- Attention deficit-hyperactivity disorder in adult bipolar disorder patients. (2019) (29)
- Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters. (2004) (29)
- Prolonged pharmacologic activity of neuroleptics. (1985) (29)
- Open trial of bupropion SR in adolescent major depression. (2003) (29)
- A clinical report of thymoleptic-responsive atypical paranoid psychoses. (1983) (28)
- Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis (2017) (28)
- Diester derivatives as apomorphine prodrugs. (1976) (28)
- Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. (1983) (28)
- Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain. (1990) (28)
- Cycloid Psychoses Revisited: Case Reports, Literature Review, and Commentary (2008) (27)
- Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. (2007) (27)
- Psychopathology factors in first-episode affective and non-affective psychotic disorders. (2007) (27)
- Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study (2016) (27)
- Physostigmine treatment of delirium induced by anticholinergics. (1976) (27)
- LITHIUM WITHDRAWAL IN BIPOLAR DISORDER: IMPLICATIONS FOR CLINICAL PRACTICE AND EXPERIMENTAL THERAPEUTICS RESEARCH (1996) (27)
- Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: Common targets for typical and atypical antepsychotic drugs (1998) (27)
- Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium (2021) (27)
- Differences between antipsychotic drugs in persistence of brain levels and behavioral effects (2005) (27)
- Amphetamine‐induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum (1973) (27)
- Intoxication associated with lithium and ECT. (1980) (27)
- Capgras' Syndrome in First-Episode Psychotic Disorders (2014) (26)
- Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity. (2008) (26)
- N-Substituted Analogues of 2β-Carbomethoxy-3β-(4′-iodophenyl) tropane (β-CIT) with Selective Affinity to Dopamine or Serotonin Transporters in Rat Forebrain. (1996) (26)
- Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. (2014) (26)
- Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter. (2001) (26)
- Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain. (1992) (26)
- Biomedical aspects of depression and its treatment (1983) (26)
- Monoamine oxidase activity in cultured human skin fibroblasts. (1977) (26)
- Behavioral effects of (−)10, 11-methylenedioxy-n-n-propylnoraporphined, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines (1982) (26)
- Adenosylmethionine Elevation in Leukemic White Blood Cells (1965) (26)
- Delirium during clozapine treatment: incidence and associated risk factors. (2003) (25)
- Role of Dopamine in Behavioral Effects of Serotonin Microinjected into Rat Striatum (1997) (25)
- Effect of age on behavioral responses and tissue levels of apomorphine in the rat (1984) (25)
- Temperaments in psychotic and major affective disorders. (2018) (25)
- Actions of (±)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain (1994) (25)
- Dopamine Receptors and Clinical Medicine (1997) (25)
- Early-life stress and psychiatric disorders: epidemiology, neurobiology and innovative pharmacological targets. (2015) (25)
- S(+)apomorphines selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat (1985) (24)
- An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine. (1982) (24)
- Prevention of suicidal behavior in bipolar disorder (2020) (24)
- Enhancing treatment with psychotropic medicines. (1994) (24)
- Clozapine-associated neutropenia and agranulocytosis in Argentina (2007–2012) (2015) (24)
- “On Cyclic Insanity” by Karl Ludwig Kahlbaum, MD: A Translation and Commentary (2003) (24)
- Hydrolysis of diester prodrugs of apomorphine. (1977) (24)
- Treatise on Insanity in Pregnant, Postpartum, and Lactating Women (1858) by Louis‐Victor Marcé: A Commentary (2009) (23)
- Dose-catalepsy response to haloperidol in rat: Effects of strain and sex (1988) (23)
- Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment (2012) (23)
- Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat. (1986) (23)
- Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness (2012) (23)
- Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs. (1988) (23)
- Pharmacology of the Amphetamines. (1972) (23)
- Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. (1990) (22)
- Treatment of Cyclothymic Disorder: Commentary (2011) (22)
- Tryptophan and Kynurenine Metabolites: Are They Related to Depression? (2018) (22)
- Melancholic versus Nonmelancholic Major Depression Compared. (2020) (22)
- Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. (1981) (22)
- Effects of alkylating agents on dopamine D3 receptors in rat brain: selective protection by dopamine (1999) (22)
- Receptor affinities of aporphine enantiomers in rat brain tissue. (1994) (22)
- Inhibition of catechol-O-methyl transferase by catechols and polyphenols. (1973) (22)
- The Impact of Psychopharmacology on Contemporary Psychiatry (2014) (22)
- Impairment of left ventricular function early in treatment with clozapine: a preliminary study (2015) (21)
- Effects of the isomers of N-n-propylnorapomorphine and haloperidol on regional concentrations of neurotensin in rat brain. (1991) (21)
- Secular trends in first hospitalizations for major mood disorders with comorbid substance use. (2006) (21)
- Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder. (2015) (21)
- Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor (2004) (21)
- Effects of maturation and aging on behavioral responses to haloperidol in the rat (2004) (21)
- Esters of apomorphine and N,N-dimethyldopamine as agonists of dopamine receptors in the rat brain in vivo (1975) (21)
- Circadian changes in the distribution and effects of haloperidol in the rat (1982) (20)
- Symposium: behavior modification by drugs. I. Pharmacology of the amphetamines. (1972) (20)
- History of Bipolar Manic-Depressive Disorder (2015) (20)
- Association of suicidal risk with ratings of affective temperaments. (2018) (20)
- Prenatal and early postnatal β-adrenergic receptor-mediated increase of cyclic AMP in slices of rat brain (1979) (20)
- Heterogeneity of schizoaffective disorder compared with schizophrenia and bipolar disorder (2013) (20)
- Critical issues on the use of network meta-analysis in psychiatry. (2014) (20)
- Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors (1998) (20)
- Effects of prenatal treatment of rats with haloperidol due to altered drug distribution in neonatal brain (1981) (20)
- Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective (2015) (20)
- Schizophrenia, 3rd ed (2012) (20)
- Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species. (1984) (19)
- Clinical and Environmental Risk Factors for Bipolar Disorder: Review of Prospective Studies (2018) (19)
- Synthesis and dopamine receptor binding of sulfur-containing aporphines. (2006) (19)
- Antioxidants fail to inhibit depletion of striatal dopamine by MPTP (1986) (19)
- Plasma levels of apomorphine following intravenous, intraperitoneal and oral administration to mice and rats. (1979) (19)
- Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center. (2015) (19)
- Risk rates for depression. (1984) (19)
- Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain (2000) (19)
- Dosing of Antipsychotic Agents in Pediatric Populations (1995) (19)
- Methionine-activating Enzyme and Catechol-O-methyl Transferase Activity in Normal and Leukaemic White Blood Cells (1966) (18)
- Maintenance Pharmacological Treatment of Juvenile Bipolar Disorder: Review and Meta-Analyses (2019) (18)
- Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. (1990) (18)
- Bromocriptine antagonizes behavioral effects of cocaine in the rat. (1989) (18)
- R(−) and s(+) stereoisomers of 11-hydroxy- and 11 -methoxy-N-n -propylnoraporphine: Central dopaminergic behavioral activity in the rat (1990) (18)
- N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. (1996) (18)
- Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics. (2017) (17)
- Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). (1992) (17)
- Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients. (2010) (17)
- Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. (2001) (17)
- Factors associated with suicide: Case-control study in South Tyrol. (2018) (17)
- Depression: point-prevalence and sociodemographic correlates in a Buenos Aires community sample. (2012) (17)
- Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. (1985) (17)
- Late changes in cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats (1985) (17)
- Epilepsy: Risk of suicidal behavior with antiepileptic drugs (2010) (17)
- Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat (1979) (17)
- Teaching ethics of psychopharmacology research in psychiatric residency training programs (2003) (17)
- Plasma corticosterone and cortisol following dexamethasone in psychiatric patients (1985) (17)
- Suicidal risks with psoriasis and atopic dermatitis: Systematic review and meta-analysis. (2020) (17)
- A summary of current knowledge of tardive dyskinesia. (1988) (17)
- A Putative Relationship between Valproic Acid and Polycystic Ovarian Syndrome: Implications for Treatment of Women with Seizure and Bipolar Disorders (2003) (17)
- Risks vs. benefits of antipsychotic drugs. (1973) (17)
- Tardive Dyskinesia: An Evaluation of the Etiologic Association with Neuroleptic Therapy (1974) (16)
- Tissue levels of N-n-propylnorapomorphine after treatment with (−)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors (1982) (16)
- Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes (1982) (16)
- Early clinical predictors and correlates of long-term morbidity in bipolar disorder (2017) (16)
- Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors (1998) (16)
- Switching between Clozapine and Risperidone Treatment (1997) (16)
- Synthesis and monoamine transporter affinity of 3′-analogs of 2-β-carbomethoxy-3-β-(4′-iodophenyl)tropane (β-CIT) (2004) (16)
- 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships. (1995) (16)
- Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro. (1980) (16)
- Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type. (2007) (16)
- Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients. (2010) (16)
- Letter: Grams of antipsychotics? (1976) (16)
- Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary (2017) (16)
- Status of psychotropic drug blood level assays and other biochemical measurements in clinical practice. (1979) (16)
- Inhibition of catechol‐O‐methyl transferase by l‐dopa and decarboxylase inhibitors (1972) (15)
- Age at menarche predicts age at onset of major affective and anxiety disorders (2017) (15)
- The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects. (1979) (15)
- Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. (2003) (15)
- Selection of neuroleptic dosage. (1985) (15)
- Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine. (1982) (15)
- Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials (2021) (15)
- Pharmacology of [3H]apomorphine binding to bovine brain tissue. (1981) (15)
- Characteristics of bipolar disorder patients given antidepressants (2012) (15)
- Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi (1997) (15)
- Glutamate accumulation by human gliomas and meningiomas in tissue culture (1976) (15)
- Clinical and epidemiologic aspects of tardive dyskinesia. (1985) (15)
- Atypical antipsychotic drugs and the risk of sudden cardiac death. (2009) (15)
- Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue. (2005) (14)
- Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. (2007) (14)
- Motor Activity and Antidepressant Drugs: A Proposed Approach to Categorizing Depression Syndromes and Their Animal Models (1989) (14)
- A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs. (1986) (14)
- Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. (1994) (14)
- Discontinuing psychotropic agents (1999) (14)
- Clinical Management of Suicidal Risk (2015) (14)
- Rigid analogues of dopamine: synthesis and interaction of 6-exo- and 6-endo-(3',4'-dihydroxyphenyl)-2-azabicyclo[2.2.2]octanes with dopamine uptake sites and receptors. (1982) (14)
- Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial (2015) (14)
- Prolonged antidopaminergic actions of single doses of butyrophenones in the rat (1985) (14)
- Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients (2014) (14)
- Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region (2020) (14)
- Timing and risk of bone marrow depression by psychotropic drugs. (1977) (14)
- Comparison of solid-phase radioimmunoassay and competitive protein binding method for post-dexamethasone cortisol levels in psychiatric patients (1983) (14)
- Atypical neuroleptics, dose-response relationships, and treatment-resistant psychosis. (1989) (14)
- Major depression in hospitalized Argentine general medical patients: Prevalence and risk factors. (2016) (14)
- Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter. (2002) (14)
- Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines. (2008) (14)
- Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders (2018) (14)
- Effects of medical interventions on suicidal behavior. Introduction. (1999) (14)
- Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II (2016) (14)
- BIOCHEMICAL, BEHAVIORAL, AND PHARMACOLOGIC STUDIES OF THE EFFECTS OF DIHYDROXYTRYPTAMINES IN THE RODENT BRAIN * (1978) (13)
- Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide (1978) (13)
- Toxicity and Side Effects of Antipsychotic, Antimanic, and Antidepressant Medications (1976) (13)
- The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action. (1979) (13)
- Multisite international collaborative clinical trials in mania. (2011) (13)
- Dr. Baldessarini and Colleagues Reply (1995) (13)
- Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue. (1983) (13)
- Effects of isoproterenol on the development of β-adrenergic receptors in brain cell aggregates (1981) (13)
- Methionine adenosyltransferase. A double-isotope derivative, enzymatic assay. (1972) (13)
- Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection. (1984) (13)
- Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation. (1990) (13)
- Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat (1992) (12)
- Non‐specific actions of dihydroxylated tryptamines in the central nervous system of the rat (1974) (12)
- Discontinuing psychotropic drug treatment (2020) (12)
- Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine (1980) (12)
- Assessment of treatment response in mania: commentary and new findings. (2003) (12)
- Chapter 2: The Tardive Dyskinesia Syndrome Daniel Tarsy (1976) (12)
- Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist. (1980) (12)
- R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. (2007) (12)
- Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs. (1988) (12)
- Suicide risk during anticonvulsant treatment (2010) (12)
- Combinations of mood-stabilizers with antipsychotics as treatment strategies in hospitalized psychiatric patients (2006) (12)
- Synthesis and monoamine transporter affinity of 2β-carbomethoxy-3β-(2″-, 3″- or 4″-substituted) biphenyltropanes (2000) (12)
- The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses. (2016) (12)
- R(−)2-fluoro-n-n-propylnorapomorphine: A very potent and D2-selective dopamine agonist (1991) (11)
- Dr. Arana and Associates Reply (1985) (11)
- Research methods in psychiatric treatment studies. Critique and proposals (2005) (11)
- Schizophernia: A Critique of Recent Genetic-biochemical Formulations (1965) (11)
- Manic-Depressive Illness in Children: An Early Twentieth-Century View by Theodor Ziehen (1862–1950). Introduction (2004) (11)
- Haloperidol levels and clinical response. (1981) (11)
- R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue. (1991) (11)
- LACK OF ENHANCEMENT OF DIMETHYLTRYPTAMINE FORMATION IN RAT BRAIN AND RABBIT LUNG IN VIVO BY METHIONINE OR S‐ADENOSYLMETHIONINE (1978) (11)
- Metabolism of L-dopa after inhibition of catechol-O-methyl transferase. (1972) (11)
- Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency. (2005) (11)
- Aggression among 216 patients with a first-psychotic episode of bipolar I disorder (2018) (11)
- Effects of 5,6‐dihydroxytryptamine on the metabolism of 5‐hydroxytryptamine in the central nervous system of the rat (1973) (11)
- Predicting desipramine levels in children and adolescents: a naturalistic clinical study. (1997) (11)
- Is there a long-term protective effect of mood-altering agents in unipolar depressive disorder? (1988) (11)
- Fatty Acid Derivatives of Clozapine: Prolonged Antidopaminergic Activity of Docosahexaenoylclozapine in the Rat (2001) (11)
- Nigrostriatal dopaminergic denervation enhances dopamine D4 receptor binding in rat caudate–putamen (2001) (11)
- Cyclopentadienyltricarbonylrheniumbenzazepines: synthesis and binding affinity. (2000) (11)
- Cyclothymia, a circular mood disorder. (2003) (10)
- Metabolic Hypotheses in Schizophrenia (1975) (10)
- Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists (2010) (10)
- A stereochemical and conformational model of dopaminergic agonist and antagonist activity: further evaluation. (1987) (10)
- The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management (2022) (10)
- Effects of L-DOPA and L-3-O-methyl-DOPA on uptake of (3H)L-methionine by synaptosomes. (1972) (10)
- Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001. (2009) (10)
- Factors Associated With Antidepressant Dosing in Asia: Findings From the Research on Asian Psychotropic Prescription Study (2016) (10)
- Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal Risk. (2013) (10)
- Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands. (1999) (10)
- Chapter 3: The Usefulness of Physostigmine in Neurology and Psychiatry (1976) (10)
- Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus (1984) (10)
- Psychotic Reactions during Amitriptyline Therapy (1968) (10)
- [191] Assay of tissue levels of S-adenosylmethionine (1971) (10)
- Using physostigmine safely. (1979) (10)
- Dopamine D4 receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization (2000) (10)
- Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both (2006) (10)
- A Concise Guide to Understanding Suicide: Reduction of suicidal behavior in bipolar disorder patients during long-term treatment with lithium (2014) (9)
- Synthesis, radiolabeling and baboon SPECT imaging of 2β-carbomethoxy-3β-(3′-[123I]iodophenyl)tropane ([123I]YP256) as a serotonin transporter radiotracer (2008) (9)
- Effects of nigrostriatal dopamine denervation on ionotropic glutamate receptors in rat caudate-putamen (2000) (9)
- Testing for Antisuicidal Effects of Lithium Treatment. (2021) (9)
- Risk of suicide and all-cause mortality after self-harm. (2015) (9)
- Circadian changes in behavioral effects of haloperidol in rats (2004) (9)
- Methylation hypothesis. (1979) (9)
- Severe daytime somnolence in patients treated with an MAOI. (1988) (9)
- Factors associated with single versus multiple suicide attempts in depressive disorders. (2020) (9)
- Defining and managing suicidal risk in patients taking psychotropic medications. (2009) (9)
- Andrés Piquer-Arrufat (1711-1772): contributions of an eighteenth-century spanish physician to the concept of manic-depressive illness. (2011) (9)
- [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue. (1999) (9)
- Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging. (2002) (9)
- Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents. (2004) (9)
- S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system (1987) (9)
- Pharmacological treatment of bipolar depression (2014) (9)
- Γ-AMINOBUTYRIC ACID ESTERS. 2. SYNTHESIS, BRAIN UPTAKE, AND PHARMACOLOGICAL PROPERTIES OF LIPID ESTERS OF Γ-AMINOBUTYRIC ACID (1985) (9)
- Selective Dopamine D4 Receptor Antagonists: Review ofStructure-Activity Relationships (2002) (9)
- Arsenic: Association of regional concentrations in drinking water with suicide and natural causes of death in Italy (2017) (9)
- Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. (1997) (9)
- The noradrenergic system in cultured aggregates of fetal rat brain cells: Morphology of the aggregates and pharmacological indices of noradrenergic neurons (1981) (9)
- EFFECTS OF AMPHETAMINES ON THE METABOLISM OF CATECHOLAMINES IN THE RAT BRAIN (1974) (9)
- Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men (2014) (8)
- Special treatment issues: maintaining and discontinuing psychotropic medications. (1997) (8)
- Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders. (2010) (8)
- Latency, discontinuation and re-use of lithium treatment (2006) (8)
- Definition and management of suicidality in psychiatric patients. (2009) (8)
- Fluoxetine inhibits desipramine metabolism. (1992) (8)
- Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine. (1991) (8)
- Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse (1977) (8)
- Movement Disorders Induced by Psychotherapeutic Agents (1986) (8)
- Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) study. (2010) (8)
- Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients (2011) (8)
- Suicide: Clinical/Risk Management Issues for Psychiatrists (2000) (8)
- The Age of Onset of Bipolar Disorders (2018) (8)
- FACTORS INFLUENCING S-ADENOSYLMETHIONINE LEVELS IN MAMMALIAN TISSUES (1967) (8)
- Lithium and Suicide Risk in Bipolar Disorder (2000) (8)
- Comparison of mania patients suitable for treatment trials versus clinical treatment (2008) (7)
- Improved high-affinity binding of 3H-apomorphine with a subcellular membrane fraction of mammalian brain tissue. (1981) (7)
- Clinical Pharmacology and Side Effects of Antipsychotic and Mood-Stabilizing Drugs used in the Treatment of Psychiatric Patients with Chronic or Recurrent Disorders (1983) (7)
- Correlation of Initial Wellness With Long-Term Morbidity in Recurrent Major Affective Disorder Patients as a Test of Survival Analysis (2010) (7)
- Antidepressant responses in direct comparisons of melancholic and non-melancholic depression (2020) (7)
- Effects of aporphine isomers on rat prolactin (1994) (7)
- Interactions of bromocriptine with cocaine. (1988) (7)
- Characteristics of tyrosine hydroxylation in isolated nerve endings. (1976) (7)
- Clozapine Withdrawal: Serotonergic or Dopaminergic Mechanisms?-Reply (1997) (7)
- Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder (2015) (7)
- Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue. (1983) (7)
- Specialized Police-Based Mental Health Crisis Response: The First 10 Years of Colorado's Crisis Intervention Team Implementation. (2017) (7)
- Advances in Development of Dopaminergic Aporphinoids (2007) (7)
- Risk of Depression Associated With Finasteride Treatment (2021) (7)
- Behavioral effects of apomorphine isomers in the rat: Selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine (2004) (7)
- The McLean-Harvard First Episode Project: Two-year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients (2009) (7)
- Unmet Needs in Psychiatry: Bipolar Depression (2020) (7)
- The Catecholamines in Psychiatric and Neurologic Disorders (1987) (7)
- Are renal tumors associated with lithium treatment? (2014) (7)
- Progressive accumbens degeneration after neonatal striatal 6-hydroxydopamine in rats (1998) (6)
- Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment (2021) (6)
- Language proficiency among hospitalized immigrant psychiatric patients in Italy (2014) (6)
- Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis (2012) (6)
- Integration of suicidology with general medicine: an obligation to society. (2011) (6)
- The McLean first-episode psychosis project (1993) (6)
- Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines. (2009) (6)
- Persistence of antipsychotic drug effects and tissue levels (1989) (6)
- Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. (1986) (6)
- Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept (2022) (6)
- Re-analysis of the earliest controlled trials of imipramine. (2013) (6)
- Comparison of women with confirmed versus presumably misdiagnosed bipolar disorder. (2012) (6)
- Depression following mania (2016) (6)
- Lithium discontinuation: uncovering latent bipolar disorder? (2001) (6)
- Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain. (1994) (6)
- Overweight in Mood Disorders: Effects on Morbidity and Treatment Response. (2021) (6)
- Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis (2019) (6)
- Melancholia: does this ancient concept have contemporary utility? (2020) (6)
- Incidence of extrapyramidal syndromes and tardive dyskinesia. (2011) (6)
- Suicide: A Global Perspective (2018) (6)
- Release of3H-dopamine and Analogous monoamines from rat striatal tissue (1988) (6)
- Effects of alternative transmitter amines on cyclic AMP formation in rat brain tissue. (1979) (6)
- Clinical Use of Mood Stabilizers With Antidepressants in Asia: Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013 (2017) (6)
- Suicidal Behavior Associated with Mixed Features in Major Mood Disorders. (2020) (6)
- Relationships of affective temperament ratings to diagnosis and morbidity measures in major affective disorders (2021) (5)
- Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder (2021) (5)
- Introduction to special issue on treatment of bipolar disorder (2003) (5)
- Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study (2020) (5)
- Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ (2000) (5)
- Mood-Stabilizing Agents (2013) (5)
- Synthesis and Pharmacological Evaluation of 1‐Phenyl‐3‐amino‐1,2,3,4‐ tetrahydronaphthalenes as Ligands for a Novel Receptor with σ‐ Like Neuromodulatory Activity. (1994) (5)
- Synthesis and monoamine transporter affinity of new 2β-carbomethoxy-3β-[aryl or heteroaryl]phenyltropanes (2006) (5)
- Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat (1976) (5)
- Long-term lithium for bipolar disorder. (2001) (5)
- Letter to the Editor of the Journal of Affective Disorders (2002) (5)
- Origins of Psychiatric Hospitalization in Medieval Spain (2012) (5)
- Introduction. Effects of Medical Interventions on Suicidal Behavior (1999) (5)
- Ziprasidone: First Year Experience in a Hospital Setting (2004) (4)
- Nature and Management of Co-occurring Psychiatric Illnesses in Bipolar Disorder Patients (2015) (4)
- International Consensus Study of Antipsychotic Dosing (2014) (4)
- Illness history: Not associated with remission during treatment of major depression in 515 mood disorder patients. (2016) (4)
- Clinical dosing of neuroleptics. (1993) (4)
- Prolonged decrease of serum prolactin in rat by an ester prodrug of apomorphine (1979) (4)
- DIESTER DERIVATIVES AS APOMORPHINE PRODRUGS (1976) (4)
- Amphetamine accelerates and attenuates ultradian activity rhythms in preweanling rats (1988) (4)
- Commentary: Lithium treatment for bipolar disorder (2020) (4)
- Age-at-Onset of 648 Patients with Major Affective Disorders: Clinical and Prognostic Implications (2011) (4)
- Risks in discontinuation trials with antidepressants. (2014) (4)
- Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone (1999) (4)
- Reply to Potvin et al. 2006 regarding comorbid substance-use in schizophrenia (2007) (4)
- Synthesis of [N‐C3H3]‐trans‐(1R,3S)‐(−)‐1‐Phenyl‐3‐N,N‐dimethylamino‐1,2,3,4‐tetrahydronaphthalene (H2‐PAT) (1994) (4)
- Regulation of psychiatric practice. (1986) (4)
- Medication removal and research in psychotic disorders. (1998) (4)
- Antipsychotics and their Side Effects: Introduction (2010) (4)
- Early clinical predictors of long‐term morbidity in major depressive disorder (2018) (4)
- Characteristics Associated with Depression Severity in 270 Juveniles in a Major Depressive Episode (2021) (4)
- Prodromal features in first-psychotic episodes of major affective and schizoaffective disorders. (2021) (3)
- Factors associated with onset‐age in major affective disorders (2022) (3)
- Methylation in Schizophrenia: An Old Hypothesis Revisited (1979) (3)
- Methodological considerations regarding Joyce et al. 2016 (2017) (3)
- Relapse of depressive symptoms after discontinuing sertraline. (1999) (3)
- Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents (2005) (3)
- Update on the management of bipolar illness. (1998) (3)
- Suicidal behavior in juvenile bipolar disorder and major depressive disorder patients: Systematic review and meta-analysis. (2022) (3)
- Fertility rates in patients with mood disorder in Sweden and Sardinia. (2013) (3)
- Transitions: Athanasios Koukopoulos [AθανάσιΟς κΟυκόπΟυλΟς], M.D. (1931–2013) (2013) (3)
- Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites (1998) (3)
- APORPHINES. 30. (-)-N-(2-CHLOROETHYL)-10,11-DIHYDROXYNORAPORPHINE (CHLOROETHYLNORAPOMORPHINE), NOVEL IRREVERSIBLE DOPAMINE RECEPTOR ANTAGONIST (1980) (3)
- A novel SCL-90-R six-item factor identifies subjects at risk of early adverse outcomes in public mental health settings (2018) (3)
- N-Phthalimidoalkyl derivatives of 2β-carbomethoxy-3β-(4′-iodophenyl)tropane (β-CIT): Brain monoamine transporter affinity (1997) (3)
- Viral Encephalopathy and Psychosis (1976) (3)
- Synthesis and Monoamine Transporter Affinity of 3′‐Analogues of 2‐β‐Carbomethoxy‐3‐β‐(4′‐iodophenyl)tropane (β‐CIT). (2004) (3)
- Synthesis of [N-C3H3]-racemic-trans-1-phenyl-3-dimethylamino-6-chloro-7-hydroxy-1,2,3,4-tetrahydronaphthalene (PAT-6) (1992) (3)
- Is Electroconvulsive Therapy a Treatment for Depression Following Traumatic Brain Injury (2018) (3)
- Factors Associated with Costs of Hospitalization of Severely Mentally Ill Patients (2016) (3)
- S(+)-aporphines as potential limbic-selective antipsychotic agents (1991) (3)
- Psychosis NOS: search for diagnostic clarity. (2008) (3)
- Comprehensive Care of Schizophrenia: A Textbook of Clinical Management, 2nd ed (2015) (3)
- Protective effect of pregnancy on the course of lithium-responsive bipolar I disorder. (2002) (3)
- What can we learn about brain donors? Use of clinical information in human postmortem brain research. (2018) (3)
- Forty Years of Lithium Treatment (1998) (3)
- Risks of antipsychotic drugs overemphasized. (1981) (2)
- Clinical Psychopharmacology: Principles and Practice. (2020) (2)
- Atrial Fibrillation and Injected Aripiprazole: A Case Report. (2018) (2)
- The Utility of the Dexamethasone Suppression Test-Reply (1987) (2)
- [Enduring pain I. Nosology and epidemiology]. (2013) (2)
- Psychotropic medicines: increased appetite rather than weight gain. (2022) (2)
- Selective probes for characterization of dopamine D1 and D2 receptors (1992) (2)
- Γ-AMINOBUTYRIC ACID ESTERS. I. SYNTHESIS, BRAIN UPTAKE, AND PHARMACOLOGICAL STUDIES OF ALIPHATIC AND STEROID ESTERS OF Γ-AMINOBUTYRIC ACID (1984) (2)
- Long‐term morbidity in major affective and schizoaffective disorders following hospitalization in first psychotic episodes (2020) (2)
- Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings (2019) (2)
- False neurochemical transmitters and disordered function of the CNS (1974) (2)
- Dr. Centorrino and Colleagues Reply (2005) (2)
- Commentary: the current state of psychopharmacology and psychiatry. (2011) (2)
- Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders (2022) (2)
- Suicide in psychiatric disorders: rates, risk factors, and therapeutics (2021) (2)
- Stereochemical Effects of Mono‐ and Dihydroxyaporphines on Presynaptic Inhibition of Dopamine Synthesis In Vitro a (1990) (2)
- Antipsychotics and their Side Effects: Agranulocytosis and other blood dyscrasias (2010) (2)
- Synthesis and Monoamine Transporter Affinity of New 2β-Carbomethoxy-3β-[4-(substituted thiophenyl)]phenyltropanes: Discovery of a Selective SERT Antagonist with Picomolar Potency. (2005) (2)
- Child and Adolescent Clinical Features Preceding Adult Suicide Attempts (2017) (2)
- Lack of depletion of striatal dopamine by phenylpiperidine analgesics. (1986) (2)
- Suicidal risk during antidepressant treatment. (2011) (2)
- Biological rhythms in mood disorders: from phenomenology to nonlinear dynamics of temporality (2014) (2)
- Efficacy of the Cooperative Assessment Method (COOPAS) to Improve the Psychiatric Care of Help-Seeking Adolescents (2019) (2)
- Efficacy of antidepressants in juvenile depression (2008) (2)
- Clozapine Toxicity Associated with Smoking Cessation (2005) (2)
- International Study of Antipsychotic Dosing (2014) (2)
- Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM. (2003) (2)
- Risk factors for early recurrence after discontinuing lithium in bipolar disorder (2022) (2)
- Effects of selective monoaminergic reuptake blockade on activity rhythms in developing rats (2004) (2)
- Nonisotopic surrogates for technetium as ligands for monoamine transporters. (1999) (2)
- “Switching” of Mood From Depression to Mania With Antidepressants (2013) (2)
- Synthesis and monoamine transporter affinity of 2β-carbomethoxy-3β-(4′- p -substituted phenyl)-piperidine analogs of cocaine (2006) (2)
- Therapeutic and Diagnostic Agents for Parkinson’s Disease (2010) (2)
- N‐Monofluoroalkylnoraporphines: Synthesis and Binding Dopamine Receptor Studies. (1993) (2)
- APORPHINES. 39. SYNTHESIS, DOPAMINE RECEPTOR BINDING, AND PHARMACOLOGICAL ACTIVITY OF (R)-(-)- AND (S)-(+)-2-HYDROXYAPOMORPHINE (1983) (2)
- Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine (2005) (2)
- Compounds antagonistic to norepinephrine retention by rat brain homogenates. (1971) (2)
- Steroids and antidepressant response (2019) (2)
- Litio en Psiquiatría. / Lithium in Psychiatry. (2014) (1)
- Lithium in Psychiatry. (2013) (1)
- Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver. (1988) (1)
- Antidepressant-Antianxiety Agents (2013) (1)
- Risk of mania with antidepressants. Authors' reply (2005) (1)
- APORPHINES. 48. ENANTIOSELECTIVITY OF (R)-(-)- AND (S)-(+)-N-N-PROPYLNORAPOMORPHINE ON DOPAMINE RECEPTORS (1983) (1)
- Further Studies of Effects of Finasteride on Mood and Suicidal Risk. (2021) (1)
- Antipsychotics and their Side Effects by David M. Gardner (2010) (1)
- Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue (1987) (1)
- Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT). (2004) (1)
- Long-Term Treatment of Bipolar Disorder with Valproate: Updated Systematic Review and Meta-analyses (2021) (1)
- Intensely Suicidal Behavior with a First Manic Episode. (2015) (1)
- APORPHINES. 36. DOPAMINE RECEPTOR INTERACTIONS OF TRIHYDROXYAPORPHINES. SYNTHESIS, RADIORECEPTOR BINDING, AND STRIATAL ADENYLATE CYCLASE STIMULATION OF 2,10,11-TRIHYDROXYAPORPHINES IN COMPARISON WITH OTHER HYDROXYLATED APORPHINES (1982) (1)
- Synthesis and Monoamine Transporter Affinity of New 2β‐Carbomethoxy‐3β‐[aryl or heteroaryl]phenyltropanes. (2006) (1)
- Perinatal screening for depression. (2010) (1)
- Synthesis, radiolabeling and preliminary evaluation of 2β‐Carbomethoxy‐3β‐(3”‐methoxypyridyl)tropane (YP186), a potential radioligand for the serotonin transporter (2001) (1)
- Cognitive functioning in outpatients diagnosed with schizophrenia, with and without comorbid alcohol abuse (2015) (1)
- Comparison of immediate and sustained release formulations of lithium salts (2022) (1)
- Antipsychotics and their Side Effects: Obesity and weight gain (2010) (1)
- Bipolar (Manic-Depressive) Disorder (2015) (1)
- Can sophisticated methods of evidence synthesis offer better clinical decision making tools for the treatment of bipolar mania (2012) (1)
- Dexamethasone suppression test. (1983) (1)
- Status and Prospects for Psychopharmacology (2013) (1)
- R‐ and S‐Enantiomers of 11‐Hydroxy‐ (Ia) and 10,11‐Dihydroxy‐N‐ allylnoraporphine (Ib): Synthesis and Affinity for Dopamine Receptors in Rat Brain Tissue. (1991) (1)
- Lithium Carbonate for Affective Disorders (2017) (1)
- Stereoisomeric, Photoaffinity, Affinity and Fluorescent Probes for Characterization of Dopamine D1 and D2 Receptors (1992) (1)
- Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study (2022) (1)
- Effects of amphetamines on the metabolism of catecholamines in the rat brain. (1974) (1)
- Strategies to prevent suicide. (2006) (1)
- Psychosocial Treatments in Psychotic Disorders (2004) (1)
- Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment (2017) (1)
- APOMORPHINE PRODRUG DERIVATIVES AS LONG-ACTING DOPAMINE RECEPTOR ACTIVE AGENTS WITH POTENTIAL CLINICAL UTILITY (1979) (1)
- Regional Considerations in the Use of Antipsychotic Drugs (1993) (1)
- Suicidal risks in rural versus urban populations in Sardinia. (2021) (1)
- 493. An open trial of Wellbutrin SR in adolescents with depression (2000) (0)
- Antipsychotics and their Side Effects: Neuroleptic malignant syndrome (2010) (0)
- Development of Polyfluorophenyltropanes: Potential Probes for 19F Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Assessments of the Dopamine Transporter (2005) (0)
- Developmental differences in response to haloperidol: Regional dopamine turnover (1989) (0)
- Antipsychotics and their Side Effects: Hepatic effects (2010) (0)
- Letter: Comments on "an overview of schizophrenia". (1974) (0)
- Letter from Ross J. Baldessarini to Robert Michels (1979) (0)
- Cortex, Vol. XXIII (1986), N. 4, P. 499-519 (1987) (0)
- Irreversible ligands for dopamine D-2 receptors (1990) (0)
- Books received (2005) (0)
- Antipsychotics and their Side Effects: Zuclopenthixol (2010) (0)
- Antipsychotics and their Side Effects: Seizures (2010) (0)
- of cardiac abnormalities associated with clozapine Report Type Diagnosis Findings (2016) (0)
- Contents of the American Journal of Psychiatry (1995) (0)
- Salute to Our Reviewers. (2019) (0)
- SYMPOSIUM: BEHAVIOR MODIFICATION BY DRUGS (1972) (0)
- P.2.e.005 The McLean–Harvard First Episode Project: two-year functional recovery in 152 first-episode bipolar-I disorder patients (2011) (0)
- Lithium in Breast Milk and Nursing Infants: Clinical Implications (2007) (0)
- Antipsychotics and their Side Effects: Methotrimeprazine (2010) (0)
- Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology (2022) (0)
- Selective dopamine/serotonin receptors mediate actions of newer antipsychotic agents (2002) (0)
- Antipsychotics and their Side Effects: Quetiapine (2010) (0)
- A Critical Moment in Psychiatry: The Need for Meaningful Psychotherapy Training in Psychiatry (2020) (0)
- Comparison of bipolar disorder type II and major depressive disorder. (2022) (0)
- An atypical, chronic psychotic disorder in a 55-year-old man. (2009) (0)
- Psychopharmacology and Neurotherapeutics (2021) (0)
- Antipsychotics and their Side Effects: Ziprasidone (2010) (0)
- High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma. (1988) (0)
- Antidepressant and Antiparkinson Drugs (2016) (0)
- Antipsychotics and their Side Effects: Pipotiazine palmitate (2010) (0)
- Interactions of drugs and amines in the brain. (1972) (0)
- α-ADRENERGIC RECEPTORS IN RAT AORTIC SMOOTH MUSCLE: EVIDENCE FOR TWO COOPERATIVELY INTERACTING POPULATIONS (1979) (0)
- Review: newer drugs have not yet been shown to be better than clozapine for schizophrenia (2001) (0)
- Antipsychotics and their Side Effects: Anticholinergic effects (2010) (0)
- Dr. Viguera and Colleagues Reply (2001) (0)
- Correct Expansion of 'ED50' Values in Clinical and Laboratory Studies (1985) (0)
- Antipsychotics and their Side Effects: Loxapine (2010) (0)
- Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression". (2008) (0)
- On the development and utilization of assays for biological transmethylation involving S-adenosylmethionine. (1978) (0)
- Antipsychotics and their Side Effects: QTc prolongation, arrhythmias, and sudden cardiac death (2010) (0)
- Can Suicide Be Prevented (2011) (0)
- Physical exercise, depression, and anxiety in 2190 affective disorder subjects. (2022) (0)
- Antipsychotics and their Side Effects: Paliperidone (2010) (0)
- Dr. Hegarty and Colleagues Reply (1995) (0)
- Antipsychotics and their Side Effects: Ocular effects (2010) (0)
- Changes in the prevalence, severity and recovery rates in tardive dyskinesia with age (1981) (0)
- Exacerbation risk following withdrawal of oral and depot neuroleptic treatment of psychotic patients (1995) (0)
- Introduction to Neuropsychopharmacology (2010) (0)
- Antipsychotics and their Side Effects: Aripiprazole (2010) (0)
- Antipsychotics and their Side Effects: Urinary incontinence (2010) (0)
- Suicidal Risk During Anticonvulsant Treatment (2010) (0)
- Effects of Treatment of Acute Major Depressive Episodes in Bipolar I Versus Bipolar II Disorders With Quetiapine (2022) (0)
- Antipsychotics and their Side Effects: Sialorrhea (2010) (0)
- The Rise and Fall of the Age of Psychopharmacology. (2022) (0)
- Antipsychotics and their Side Effects: Prolactin effects (2010) (0)
- Antipsychotics and their Side Effects: Chlorpromazine (2010) (0)
- Antipsychotics and their Side Effects: Pimozide (2010) (0)
- Antipsychotics and their Side Effects: Frequently asked questions (2010) (0)
- Synthesis and Monoamine Transporter Affinity of 2β-Carbomethoxy-3β-(2′′-, 3′′-, or 4′′-substituted) Biphenyltropanes. (2000) (0)
- Bibliography for Bipolar Disorder (2003) (0)
- Antipsychotics and their Side Effects: Guide for using the General Antipsychotic Monitoring Form (2010) (0)
- Books Received (2013) (0)
- EPA-1696 – Metabolic Outocomes Among Schizophrenia and Bipolar Disorder Patients (2014) (0)
- Biomedical Aspects of Depression and Its Tre4tment-by (1984) (0)
- Fluoxetine Potentiates Pentobarbital Lethality and Sedation in the Rat (1996) (0)
- Electricity rendered useful for mental illness: tribute to Richard Lovett – extra (2013) (0)
- Publishing & Business Staff (2015) (0)
- Dopamine D4 receptors mediate behavioral hyperactivity in juvenile rats (2002) (0)
- Antipsychotics and their Side Effects: Trifluoperazine (2010) (0)
- 2013 Daniel H. Efron Research Award (2012) (0)
- Clozapine Use for Bipolar Disorder (2023) (0)
- Monotherapy versus polypharmacy for hospitalized psychiatric patients. Authors' reply (2005) (0)
- Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry. (1988) (0)
- Antipsychotics and their Side Effects: Venous thromboembolism (2010) (0)
- Bipolar Disorder: Open Access Factors Associated with Costs of Hospitalization of Severely Mentally Ill Patients (2016) (0)
- Antipsychotics and their Side Effects: Olanzapine (2010) (0)
- Symposium S11: Dopamine‐Serotonin Interactions in Psychosis and Antipsychotic Drug Actions (2004) (0)
- Iconography : Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients (2014) (0)
- S.25.02 Treating bipolar mania: evidence based evaluation of drug and placebo responses (2011) (0)
- Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine Timothy E. Wilens, Joseph Biederman, Ross J. Baldessarini, Patricia R. Puopolo, James G. Flood Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 (1992) (0)
- Antipsychotics and their Side Effects: Thiothixene (2010) (0)
- Antipsychotics and their Side Effects: Sexual dysfunction (2010) (0)
- Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine. (2006) (0)
- The National Institute of Mental Health Career Scientist Awards. (1998) (0)
- Antipsychotics and their Side Effects: Preface (2010) (0)
- Antipsychotics and their Side Effects: Risperidone (2010) (0)
- Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat. (1973) (0)
- The lions of Granada Maristan. (2013) (0)
- Tricyclic and selective serotonin-reuptake-inhibitor antidepressants compared with placebo in randomized trials for acute major depression (2017) (0)
- Two bipolar disorders or one? In reply to commentary by Malhi and Bell (2022) (0)
- Modern Psychopharmacology and Psychiatric Treatment (2013) (0)
- Bipolar Disorder (Including Hypomania and Mania) (2001) (0)
- 215 S(+)-N-n-propylnorapomorphine ([+]-NPA): A novel atypical antipsy chotic with clozapine-like effects (1997) (0)
- 75 Localization of D4-like dopamine receptors on corticostriatal projections and intrinsic striatal neurons (1997) (0)
- Antipsychotics and their Side Effects: Pericyazine (2010) (0)
- Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(2''-, 3''- or 4''-substituted) biphenyltropanes. (2000) (0)
- Effects of L-Dopa on Norepinephrine Meta (2016) (0)
- Antipsychotics and their Side Effects: Haloperidol (2010) (0)
- Differential anatomical localization of dopamine and ionotropic glutamate receptor subtypes in caudate-putamen (1998) (0)
- Drs. Baldessarini and Cohen Reply (2006) (0)
- REPORTER'S NOTES—FIRST SESSION (1973) (0)
- P.3.002 Placebo response in trials for acute mania: a double-edged sword (2010) (0)
- Antipsychotics and their Side Effects: Flupenthixol (2010) (0)
- Salute to Our Reviewers. (2016) (0)
- RIGID ANALOGS OF DOPAMINE: SYNTHESIS AND INTERACTION OF 6-EXO- AND 6-ENDO-(3′,4′-DIHYDROXYPHENYL)-2-AZABICYCLO(2.2.2)OCTANES WITH DOPAMINE UPTAKE SITES AND RECEPTORS (1982) (0)
- JAMA Peer Reviewers in 2004 (2016) (0)
- Novel Phenyltropanes: Affinity to Monoamine Transporters in Rat Forebrain (1998) (0)
- [Enduring pain II. Treatment]. (2013) (0)
- Antipsychotics and their Side Effects: Dyslipidemia (2010) (0)
- Antipsychotics and their Side Effects: Tardive dyskinesia and other late-onset movement disorders (2010) (0)
- Antipsychotics and their Side Effects: Guide to using Antipsychotics and their Side Effects (2010) (0)
- Antipsychotics and their Side Effects: Extrapyramidal symptoms (2010) (0)
- Melancholia as a DSM-5 specifier or a separate category? (2020) (0)
- Antipsychotics and their Side Effects: Summary of monitoring recommendations for individual antipsychotics (2010) (0)
- Books Received (1987) (0)
- Antipsychotics and their Side Effects: Perphenazine (2010) (0)
- ‘Atypical’ antipsychotics: how far have we come? (2001) (0)
- EPS volume 18 issue 3 Cover and Back matter (2009) (0)
- Drs. Tondo and Baldessarini Reply (1999) (0)
- Antipsychotics and their Side Effects: Molindone (2010) (0)
- Editorial: Metabolic hypotheses in schizophrenia. (1975) (0)
- Rescuing an Essential Component of Psychiatry: Psychotherapy Training in Psychiatric Education (2020) (0)
- Antipsychotics and their Side Effects: Fluphenazine (2010) (0)
- On Sandoz's claim of thioridazine's comparative safety. (1983) (0)
- Factors Associated with Depression Severity in Adolescence (2017) (0)
- Antipsychotics and their Side Effects: Diabetes mellitus (2010) (0)
- Antipsychotics and their Side Effects: Thioridazine (2010) (0)
- Antipsychotics and their Side Effects: Sedation and sleep disturbances (2010) (0)
- Antipsychotics and their Side Effects: Clozapine (2010) (0)
- Nonantipsychotic phenothiazines and tardive dyskinesia. (1973) (0)
- Antipsychotics and their Side Effects: Purpose, development, and limitations of Antipsychotics and their Side Effects (2010) (0)
- Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[aryl or heteroaryl]phenyltropanes. (2006) (0)
- GO Select One ADD / ADHD Alcoholism Alzheimer ' s Get Info Now Psychosocial Treatments in Bipolar Disorder (2003) (0)
- Antipsychotics and their Side Effects: Overview of the General Antipsychotic Monitoring Form (2010) (0)
- Antipsychotics and their Side Effects: Vital signs (2010) (0)
- Antipsychotics and their Side Effects: Skin and hypersensitivity reactions (2010) (0)
- Epidemiology of Tardive Dyskinesia (1985) (0)
- Corrigendum to "Temperaments in psychotic and major affective disorders" [J. Affect. Disord. (2018) 195-200]. (2018) (0)
- Bipolar Depression: An Orphan Syndrome? (2015) (0)
- Pramipexole augments benefits of atypical antipsychotics in patients with schizophrenia or schizoaffective disorder (2003) (0)
- JAMA Peer Reviewers for 2003 (2017) (0)
- Antipsychotics and their Side Effects: About the cover art (2010) (0)
- Comments on "An Overview of Schizophrenia" (1974) (0)
- Drugs Five Years Later (2020) (0)
- Title Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients : Asia psychotropic prescripton study (2011) (0)
- International suicide rates versus adequate treatments (2017) (0)
- Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer. (2008) (0)
This paper list is powered by the following services:
Other Resources About Ross J. Baldessarini
What Schools Are Affiliated With Ross J. Baldessarini?
Ross J. Baldessarini is affiliated with the following schools:
